SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-05-20
👔
Cytek Biosciences, Inc.
@CTKB_InsiderForm 4 Filing: Chin Richard Exercises Options for shares of $CTKB
OPTION EXERCISE
⚡ MATERIALITY: 2/10
corporate issuer
Cytek Biosciences, Inc.
Ticker: $CTKB
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-05-18
Shares: 6,107
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Chin Richard, holds the title of Director at Cytek Biosciences, Inc..
On 2026-05-18, the insider transacted 6,107 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Chin Richard (Director) exercised options for $0 of $CTKB
Post-Transaction Position: 22,392 shares
SEC Accession No: 0001337252-26-000002 (CIK: 1337252)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.